Literature DB >> 29050898

Sushi, ceviche and gnathostomiasis - A case report and review of imported infections.

Jordan Leroy1, Marjorie Cornu1, Anne Sophie Deleplancque2, Séverine Loridant1, Emmanuel Dutoit3, Boualem Sendid4.   

Abstract

We describe a case of imported cutaneous gnathostomiasis in a Thai patient living in France. Gnathostomiasis is a zoonosis of food origin. The disease is endemic in Southeast Asia and Latin America. However, over the past 30 years, an increasing number of imported cases has been described in Europe and America. The disease is rare in Western Europe and the majority of cases described had a cutaneous clinical presentation. The disease may sometimes be confused with allergy, leading to a delay in diagnosis. Visceral symptoms are rare but may follow severe attacks. A definitive diagnosis can be obtained by the isolation of larvae from skin biopsies, but these are rarely performed. The diagnosis is usually presumptive, based on a combination of anamnestic, clinical, and biological factors. Several courses of the anti-helminths, albendazole or ivermectin, are often necessary. Although rare, the diagnosis should be evoked systematically in a migrant or traveller returning from an endemic area with cutaneous lesions.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Cutaneous infection; Endemic; Gnathostomiasis; Nematode; Parasite; Zoonosis

Mesh:

Substances:

Year:  2017        PMID: 29050898     DOI: 10.1016/j.tmaid.2017.10.010

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  2 in total

1.  Gnathostomiasis Acquired by Visitors to the Okavango Delta, Botswana.

Authors:  John Frean
Journal:  Trop Med Infect Dis       Date:  2020-03-06

2.  Gnathostomiasis acquired after consumption of raw freshwater fish in the Amazon region: a report of two cases in Brazil.

Authors:  Vidal Haddad Junior; Ísis Fiorello de Oliveira; Natália Parenti Bicudo; Mariângela Esther Alencar Marques
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-13       Impact factor: 1.581

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.